Hua H, Long W, Pan Y, Li S, Zhou J, Wang H
Interdiscip Sci. 2024; 17(1):12-26.
PMID: 39348073
DOI: 10.1007/s12539-024-00655-6.
Duppala S, Poleboyina P, Kour B, Bale G, Vyas A, Pawar S
Indian J Microbiol. 2024; 64(3):1222-1245.
PMID: 39282199
PMC: 11399378.
DOI: 10.1007/s12088-024-01295-6.
Kiconco A, Kabanda R, Ronald A, Beyer K, John S
BMC Womens Health. 2024; 24(1):296.
PMID: 38762723
PMC: 11102156.
DOI: 10.1186/s12905-024-03129-5.
Jung L, Klamminger G, Bier B, Eltze E
Life (Basel). 2024; 14(3).
PMID: 38541633
PMC: 10971174.
DOI: 10.3390/life14030307.
Yilmaz A, Gulbahar A, Sen S
Medicine (Baltimore). 2023; 102(50):e36341.
PMID: 38115367
PMC: 10727527.
DOI: 10.1097/MD.0000000000036341.
Machine Learning Allows for Distinguishing Precancerous and Cancerous Human Epithelial Cervical Cells Using High-Resolution AFM Imaging of Adhesion Maps.
Petrov M, Sokolov I
Cells. 2023; 12(21).
PMID: 37947614
PMC: 10650179.
DOI: 10.3390/cells12212536.
Updates in Cervical Cancer Screening Guidelines, The Bethesda System for Reporting Cervical Cytology, and Clinical Management Recommendations.
Wang T, Zhang H, Liu Y, Zhao C
J Clin Transl Pathol. 2023; 3(2):75-83.
PMID: 37456763
PMC: 10348779.
DOI: 10.14218/jctp.2023.00004.
Entrectinib a Plausible Inhibitor for Osteopontin (SPP1) in Cervical Cancer-Integrated Bioinformatic Approach.
Poleboyina P, Alagumuthu M, Pasha A, Ravinder D, Pasumarthi D, Pawar S
Appl Biochem Biotechnol. 2023; 195(12):7766-7795.
PMID: 37086377
DOI: 10.1007/s12010-023-04541-7.
Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States.
Cuzick J, Adcock R, Kinney W, Castle P, Robertson M, McDonald R
Int J Cancer. 2023; 153(1):83-93.
PMID: 36946690
PMC: 10639031.
DOI: 10.1002/ijc.34519.
The effect of decision-aid-based counseling on cervical cancer screening behavior among women: An interventional study.
Malekzadeh E, Nourizadeh R, Farshbaf-Khalili A, Mehrabi E, Hakimi S
J Educ Health Promot. 2022; 11:205.
PMID: 36003249
PMC: 9393954.
DOI: 10.4103/jehp.jehp_714_21.
HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study.
Warden C, Cholli P, Qin H, Guo C, Wang Y, Kancharla C
Infect Agent Cancer. 2022; 17(1):44.
PMID: 35945577
PMC: 9361560.
DOI: 10.1186/s13027-022-00456-w.
Prevalence and distribution of selected cervical human papillomavirus types in HIV infected and HIV uninfected women in South Africa, 1989-2021: A narrative review.
Rikhotso R, Mitchell E, Wilson D, Doede A, Matume N, Bessong P
S Afr J Infect Dis. 2022; 37(1):363.
PMID: 35815224
PMC: 9257898.
DOI: 10.4102/sajid.v37i1.363.
A Comparative Study of Health Disparities in Cervical Cancer Mortality Rates Through Time Between Black and Caucasian Women in Alabama and the US.
Abdalla E, Habtemariam T, Fall S, Troy R, Tameru B, Nganwa D
Int J Stud Nurs. 2022; 6(1):9-23.
PMID: 35356704
PMC: 8963192.
DOI: 10.20849/ijsn.v6i1.864.
Role of Medicaid in Early Detection of Screening-Amenable Cancers.
Bradley C, Sabik L, Entwistle J, Stevens J, Enewold L, Warren J
Cancer Epidemiol Biomarkers Prev. 2022; 31(6):1202-1208.
PMID: 35322273
PMC: 9167742.
DOI: 10.1158/1055-9965.EPI-21-1077.
A Deep Learning Model for Cervical Cancer Screening on Liquid-Based Cytology Specimens in Whole Slide Images.
Kanavati F, Hirose N, Ishii T, Fukuda A, Ichihara S, Tsuneki M
Cancers (Basel). 2022; 14(5).
PMID: 35267466
PMC: 8909106.
DOI: 10.3390/cancers14051159.
De-implementation of cervical cancer screening before age 21.
Silver M, Anderson M, Beaber E, Haas J, Kobrin S, Pocobelli G
Prev Med. 2021; 153:106815.
PMID: 34599920
PMC: 8802556.
DOI: 10.1016/j.ypmed.2021.106815.
Clinical follow-up practices after cervical cancer screening by co-testing: A population-based study of adherence to U.S. guideline recommendations.
Perkins R, Adcock R, Benard V, Cuzick J, Waxman A, Howe J
Prev Med. 2021; 153:106770.
PMID: 34416221
PMC: 8595756.
DOI: 10.1016/j.ypmed.2021.106770.
Treatment Outcomes of Patients With Cervical Intraepithelial Neoplasia or Invasive Carcinoma Who Underwent Loop Electrosurgical Excision Procedure.
Khunnarong J, Bunyasontikul N, Tangjitgamol S
World J Oncol. 2021; 12(4):111-118.
PMID: 34349855
PMC: 8297047.
DOI: 10.14740/wjon1391.
Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States.
Cuzick J, Du R, Adcock R, Kinney W, Joste N, McDonald R
Gynecol Oncol. 2021; 162(3):555-559.
PMID: 34253387
PMC: 8405560.
DOI: 10.1016/j.ygyno.2021.06.029.
Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014.
Wright J, Chen L, Tergas A, Melamed A, St Clair C, Hou J
JAMA Netw Open. 2021; 4(4):e218373.
PMID: 33914050
PMC: 8085723.
DOI: 10.1001/jamanetworkopen.2021.8373.